3551 - 3575 of 8404 Results
Title
Year
-
OPENTitle: Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.648417Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.648417/pdfCitation Count: 10
- Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials2021RESTRICTEDTitle: Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical TrialsJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.648532Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.648532/pdfCitation Count: 21
-
OPENTitle: Hispanic Perspectives on Parkinson’s Disease Care and Research ParticipationJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 81Issue #: 2Start Page: 809End Page: 819Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jad-210231Best OA location URL: https://content.iospress.com:443/download/journal-of-alzheimers-disease/jad210231?id=journal-of-alzheimers-disease%2Fjad210231Citation Count: 17
-
RESTRICTEDTitle: Prodromal Parkinson disease — time is brainJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 17Issue #: 6Start Page: 329End Page: 330Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41582-021-00489-6Citation Count: 1
-
RESTRICTEDTitle: The 5 Pillars in Tourette Syndrome Deep Brain Stimulation Patient SelectionJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 96Issue #: 14Start Page: 664End Page: 676Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000011704Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105965Citation Count: 31
-
OPENTitle: Cognitive Profile and Markers of Alzheimer Disease–Type Pathology in Patients With Lewy Body DementiasJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 96Issue #: 14Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000011699Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105963Citation Count: 41
-
OPENTitle: Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegiaJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 5Start Page: 1122End Page: 1131Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51358Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51358Citation Count: 12
-
OPENTitle: Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central EuropeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 48End Page: 51Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.026Best OA location URL: http://manuscript.elsevier.com/S135380202100119X/pdf/S135380202100119X.pdfCitation Count: 12
- Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta‐Analysis2021RESTRICTEDTitle: Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta‐AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1293End Page: 1307Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28599Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/238481/238481.pdfCitation Count: 20
-
OPENTitle: Analysis of voice as an assisting tool for detection of Parkinson's disease and its subsequent clinical interpretationJournal Name: Biomedical Signal Processing and ControlPublisher: Elsevier BVVol: 66Issue #:Start Page: 102415End Page: 102415Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.bspc.2021.102415Best OA location URL: https://doi.org/10.1016/j.bspc.2021.102415Citation Count: 47
-
RESTRICTEDTitle: ATP1A3-Related Disorders: An Ever-Expanding Clinical SpectrumJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.637890Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.637890/pdfCitation Count: 32
-
OPENTitle: BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infectionJournal Name: CellPublisher: Elsevier BVVol: 184Issue #: 8Start Page: 2167End Page: 2182.e22Publication Date:Open Access(OA) Status: OPENLicense: elsevier-specific: oa user licenseDOI - Digital Object Identifier: 10.1016/j.cell.2021.03.026Best OA location URL: http://www.cell.com/article/S0092867421003548/pdfCitation Count: 179
-
OPENTitle: Cerebello‐Cortical Control of Tremor Rhythm and Amplitude in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1727End Page: 1729Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28603Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/238510/238510.pdfCitation Count: 32
-
OPENTitle: Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single‐particle analysis platformsJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 10Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/jev2.12079Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jev2.12079Citation Count: 147
-
OPENTitle: Disruption of the Atrophy-based Functional Network in Multiple Sclerosis Is Associated with Clinical Disability: Validation of a Meta-Analytic Model in Resting-State Functional MRIJournal Name: RadiologyPublisher: Radiological Society of North America (RSNA)Vol: 299Issue #: 1Start Page: 159End Page: 166Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1148/radiol.2021203414Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997615Citation Count: 6
- Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments2021RESTRICTEDTitle: Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New TreatmentsJournal Name: Archives of Medical ResearchPublisher: Elsevier BVVol: 52Issue #: 3Start Page: 243End Page: 251Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arcmed.2020.10.021Citation Count: 25
-
RESTRICTEDTitle: Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysisJournal Name: CancerPublisher: WileyVol: 127Issue #: 14Start Page: 2409End Page: 2422Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/cncr.33516Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.33516Citation Count: 75
-
OPENTitle: Evidence forGRNconnecting multiple neurodegenerative diseasesJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab095Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/2/fcab095/41728465/fcab095.pdfCitation Count: 33
-
OPENTitle: Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1704End Page: 1711Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28569Best OA location URL: https://repositorio.uca.edu.ar/bitstream/123456789/11645/6/fluoxetine-symptomatic-treatment-atrophy%20%281%29.pdfCitation Count: 21
-
RESTRICTEDTitle: Genetic updates on paroxysmal dyskinesiasJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 128Issue #: 4Start Page: 447End Page: 471Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-021-02335-xCitation Count: 8
-
OPENTitle: Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor SubtypesJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 7Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000557Best OA location URL: https://ng.neurology.org/content/nng/7/2/e557.full.pdfCitation Count: 38
-
RESTRICTEDTitle: Intersection of immunometabolism and immunosenescence during agingJournal Name: Current Opinion in PharmacologyPublisher: Elsevier BVVol: 57Issue #:Start Page: 107End Page: 116Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.coph.2021.01.003Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481958Citation Count: 21
-
RESTRICTEDTitle: Mindfulness based stress reduction in people with Parkinson's disease and their care partnersJournal Name: Complementary Therapies in Clinical PracticePublisher: Elsevier BVVol: 43Issue #:Start Page: 101377End Page: 101377Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ctcp.2021.101377Citation Count: 11
-
OPENTitle: Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozinJournal Name: NeoplasiaPublisher: Elsevier BVVol: 23Issue #: 4Start Page: 391End Page: 399Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neo.2021.02.003Best OA location URL: https://doi.org/10.1016/j.neo.2021.02.003Citation Count: 16
-
OPENTitle: Pilot Study to Evaluate Pimavanserin for the Treatment of Motor and Behavioral Symptoms of Tourette SyndromeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 5Start Page: 694End Page: 700Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13207Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13207Citation Count: 6